{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:07:43Z","timestamp":1773392863747,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005940","name":"Dansk Kr\u00e6ftforsknings Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R175-A11366"],"award-info":[{"award-number":["R175-A11366"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Copenhagen University Hospital Herlev and Gentofte Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1245\/s10434-022-13034-6","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T21:30:14Z","timestamp":1675891814000},"page":"2377-2388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-7961","authenticated-orcid":false,"given":"Neel Maria","family":"Helvind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Brinch-M\u00f8ller","family":"Weitemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette Hougaard","family":"Chakera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle Westergren","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Elleb\u00e6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette Wanscher","family":"Kj\u00e6rskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle","family":"Skyum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Kj\u00e6r","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille Envold","family":"Bidstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbet Rosenkrantz","family":"H\u00f6lmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"13034_CR1","unstructured":"Barbour A, Guminski A, Liu W, Menzies S, Morton R, Cancer Council Australia Melanoma Guidelines Working Party. Follow-up After Initial Definitive Treatment for Each Stage of Melanoma\u2013Cancer Guidelines Wiki, 2018. Retrieved 8 March 2022 at https:\/\/wiki.cancer.org.au\/australiawiki\/index.php?oldid=190154."},{"key":"13034_CR2","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines Version 2.2022. Melanoma: Cutaneous, 2022."},{"key":"13034_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/DDG.12113_SUPPL","volume":"11","author":"A Pflugfelder","year":"2013","unstructured":"Pflugfelder A, Kochs C, Blum A, et al. Malignant melanoma S3-guideline: diagnosis, therapy and follow-up of melanoma. JDDG J der Dtsch Dermatologischen Gesellschaft. 2013;11:1\u2013116. https:\/\/doi.org\/10.1111\/DDG.12113_SUPPL.","journal-title":"JDDG J der Dtsch Dermatologischen Gesellschaft"},{"key":"13034_CR4","unstructured":"Hendel H, Lock-Andersen J, Dahlstr\u00f8m K, et al. Opf\u00f8lgningsprogram for Moderm\u00e6rkekr\u00e6ft. Sundhedsstyrelsen 2015.; 2015. https:\/\/www.sst.dk\/da\/udgivelser\/2015\/~\/media\/06A4C4DB820A49F19311C5879672BE7D.ashx."},{"key":"13034_CR5","doi-asserted-by":"crossref","unstructured":"National Institute for Health and Care Excellence (NICE). Melanoma: Assessment and Management NICE Guideline, 2022. Retrieved 7 August 2022 at www.nice.org.uk\/guidance\/ng14.","DOI":"10.1136\/heartjnl-2022-321095"},{"key":"13034_CR6","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1016\/j.ejso.2021.06.011","volume":"47","author":"NM Helvind","year":"2021","unstructured":"Helvind NM, Aros Mardones CA, H\u00f6lmich LR, et al. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB\u2013III melanoma patients. Eur J Surg Oncol. 2021;47:3020\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2021.06.011.","journal-title":"Eur J Surg Oncol"},{"key":"13034_CR7","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1245\/S10434-020-09270-3\/TABLES\/3","volume":"28","author":"RM Turner","year":"2021","unstructured":"Turner RM, Dieng M, Khanna N, et al. Performance of long-term CT and PET\/CT surveillance for detection of distant recurrence in patients with resected stage IIIA\u2013D melanoma. Ann Surg Oncol. 2021;28:4561\u20139. https:\/\/doi.org\/10.1245\/S10434-020-09270-3\/TABLES\/3.","journal-title":"Ann Surg Oncol."},{"key":"13034_CR8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-11231-3","author":"M Dieng","year":"2022","unstructured":"Dieng M, Lord SJ, Turner RM, et al. The impact of surveillance imaging frequency on the detection of distant disease for patients with resected stage III melanoma. Ann Surg Oncol. 2022. https:\/\/doi.org\/10.1245\/s10434-021-11231-3.","journal-title":"Ann Surg Oncol"},{"key":"13034_CR9","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3832","author":"SS Ertekin","year":"2021","unstructured":"Ertekin SS, Podlipnik S, Riquelme-Mc Loughlin C, et al. Initial stage of cutaneous primary melanoma plays a key role in the pattern and timing of disease recurrence. Acta Derm Venereol. 2021. https:\/\/doi.org\/10.2340\/00015555-3832.","journal-title":"Acta Derm Venereol"},{"key":"13034_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000501398","volume":"97","author":"JW Lee","year":"2019","unstructured":"Lee JW, Nam SB, Kim SJ. Role of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography\/computed tomography for the detection of recurrent disease after treatment of malignant melanoma. Oncology. 2019;97:286\u201393. https:\/\/doi.org\/10.1159\/000501398.","journal-title":"Oncology"},{"key":"13034_CR11","unstructured":"Danish Melanoma Group. Danish Melanoma Database Annual Report 2021 (Danish title: Dansk Melanom Database \u00c5rsrapport 2021). 2022:1\u201379."},{"key":"13034_CR12","unstructured":"Danish Melanoma Group. Dansk Melanom Database. National \u00c5rsrapport 2016. Annu Rep. 2016;(December):1\u201343. https:\/\/www.sundhed.dk\/sundhedsfaglig\/kvalitet\/kliniske-kvalitetsdatabaser\/kraeft\/dansk-melanom-database\/."},{"key":"13034_CR13","unstructured":"Danish Melanoma Group. Dansk Melanom Database National \u00c5rsrapport 2017 Endelig Rapport.; 2017. www.melanoma.dk. Accessed March 9, 2020."},{"key":"13034_CR14","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S99484","author":"LR H\u00f6lmich","year":"2016","unstructured":"H\u00f6lmich LR, Klausen SSE, et al. The Danish melanoma database. Clin Epidemiol. 2016. https:\/\/doi.org\/10.2147\/CLEP.S99484.","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"13034_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1403494810393563","volume":"39","author":"B Bjerregaard","year":"2011","unstructured":"Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7 Suppl):72\u20134. https:\/\/doi.org\/10.1177\/1403494810393563.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"13034_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30\u20133. https:\/\/doi.org\/10.1177\/1403494811401482.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"13034_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22\u20135. https:\/\/doi.org\/10.1177\/1403494810387965.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"13034_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1403494811399958","volume":"39","author":"K Helweg-Larsen","year":"2011","unstructured":"Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(7 Suppl):26\u20139. https:\/\/doi.org\/10.1177\/1403494811399958.","journal-title":"Scand J Public Health"},{"key":"13034_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373\u201383.","journal-title":"J Chron Dis"},{"key":"13034_CR20","unstructured":"Aalen O. Statistics SJ-SJ of 1978 undefined: an empirical transition matrix for non-homogeneous Markov chains based on censored observations. JSTOR. Retrieved 25 May 2022 at https:\/\/www.jstor.org\/stable\/4615704."},{"key":"13034_CR21","unstructured":"R Core Team. R Foundation for Statistical Computing. R: A language and environment for statistical computing. 2022. https:\/\/www.r-project.org\/."},{"key":"13034_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/SLA.0000000000000233","volume":"259","author":"NM Rueth","year":"2014","unstructured":"Rueth NM, Xing Y, Chiang YJ, et al. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg. 2014;259:1215\u201322. https:\/\/doi.org\/10.1097\/SLA.0000000000000233.","journal-title":"Ann Surg"},{"key":"13034_CR23","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/jso.26214","volume":"122","author":"J Bleicher","year":"2020","unstructured":"Bleicher J, Swords DS, Mali ME, et al. Recurrence patterns in patients with stage II melanoma: the evolving role of routine imaging for surveillance. J Surg Oncol. 2020;122:1770\u20137. https:\/\/doi.org\/10.1002\/jso.26214.","journal-title":"J Surg Oncol"},{"key":"13034_CR24","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1245\/s10434-007-9347-2","volume":"14","author":"AB Francken","year":"2007","unstructured":"Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14:1924\u201333. https:\/\/doi.org\/10.1245\/s10434-007-9347-2.","journal-title":"Ann Surg Oncol"},{"key":"13034_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1200\/JCO.2003.01.091","volume":"21","author":"C Garbe","year":"2003","unstructured":"Garbe C, Paul A, Kohler-Sp\u00e4th H, et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol. 2003;21:520\u20139. https:\/\/doi.org\/10.1200\/JCO.2003.01.091.","journal-title":"J Clin Oncol"},{"key":"13034_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaad.2010.09.772","volume":"66","author":"U Leiter","year":"2012","unstructured":"Leiter U, Buettner PG, Eigentler TK, et al. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. J Am Acad Dermatol. 2012;66:37\u201345. https:\/\/doi.org\/10.1016\/j.jaad.2010.09.772.","journal-title":"J Am Acad Dermatol"},{"key":"13034_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"F Meier","year":"2002","unstructured":"Meier F, Will S, Ellwanger U, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 2002;147:62\u201370. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04867.x.","journal-title":"Br J Dermatol"},{"key":"13034_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/CMR.0000000000000344","volume":"27","author":"RA Leon-Ferre","year":"2017","unstructured":"Leon-Ferre RA, Kottschade LA, Block MS, et al. Association between the use of surveillance PET\/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma. Melanoma Res. 2017;27:335\u201341. https:\/\/doi.org\/10.1097\/CMR.0000000000000344.","journal-title":"Melanoma Res"},{"key":"13034_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ejso.2019.01.225","volume":"45","author":"B Leeneman","year":"2019","unstructured":"Leeneman B, Franken MG, Coup\u00e9 VMH, et al. Stage-specific disease recurrence and survival in localized and regionally advanced cutaneous melanoma. Eur J Surg Oncol. 2019;45:825\u201331. https:\/\/doi.org\/10.1016\/j.ejso.2019.01.225.","journal-title":"Eur J Surg Oncol"},{"key":"13034_CR30","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/nejmoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2019;381:1535\u201346. https:\/\/doi.org\/10.1056\/nejmoa1910836.","journal-title":"N Engl J Med"},{"key":"13034_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1056\/NEJMoa1904059","volume":"381","author":"C Robert","year":"2019","unstructured":"Robert C, Grob JJ, Stroyakovskiy D, et al. Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma. N Engl J Med. 2019;381:626\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1904059.","journal-title":"N Engl J Med"},{"key":"13034_CR32","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1245\/s10434-019-07487-5","volume":"26","author":"DW Nelson","year":"2019","unstructured":"Nelson DW, Fischer TD, Graff-Baker AN, et al. Impact of effective systemic therapy on metastasectomy in stage IV melanoma: a matched-pair analysis. Ann Surg Oncol. 2019;26:4610\u20138. https:\/\/doi.org\/10.1245\/s10434-019-07487-5.","journal-title":"Ann Surg Oncol"},{"key":"13034_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10029-004-0258-x","volume":"8","author":"AJ Duffy","year":"2004","unstructured":"Duffy AJ, Hogle NJ, LaPerle KM, Fowler DL. Comparison of two composite meshes using two fixation devices in a porcine laparoscopic ventral hernia repair model. Hernia. 2004;8:358\u201364. https:\/\/doi.org\/10.1007\/s10029-004-0258-x.","journal-title":"Hernia"},{"key":"13034_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07632-4","author":"Y Naeser","year":"2020","unstructured":"Naeser Y, Helgadottir H, Brandberg Y, et al. TRIM study protocol: a prospective randomized multicenter trial to assess the role of imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma. BMC Cancer. 2020. https:\/\/doi.org\/10.1186\/s12885-020-07632-4.","journal-title":"BMC Cancer"},{"key":"13034_CR35","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamadermatol.2015.1481","volume":"151","author":"NM Helvind","year":"2015","unstructured":"Helvind NM, H\u00f6lmich LR, Smith S, et al. Incidence of in situ and invasive melanoma in Denmark from 1985 through 2012: a national database study of 24,059 melanoma cases. JAMA Dermatol. 2015;151:1087\u201395. https:\/\/doi.org\/10.1001\/jamadermatol.2015.1481.","journal-title":"JAMA Dermatol"},{"key":"13034_CR36","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1613210.","journal-title":"N Engl J Med"},{"key":"13034_CR37","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.18.02306","volume":"37","author":"U Leiter","year":"2019","unstructured":"Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37:3000\u20138. https:\/\/doi.org\/10.1200\/JCO.18.02306.","journal-title":"J Clin Oncol"},{"key":"13034_CR38","doi-asserted-by":"publisher","unstructured":"Gershenwald JE, Scolyer RA, Hess KR et al. Melanoma staging evidence based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; Doi:https:\/\/doi.org\/10.3322\/caac.21409","DOI":"10.3322\/caac.21409"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-13034-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-13034-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-13034-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T10:10:42Z","timestamp":1679307042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-13034-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["13034"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-13034-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}